Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950123-08-001699
Filing Date
2008-02-14
Accepted
2008-02-14 16:21:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G y48352sc13g.htm SC 13G 31165
  Complete submission text file 0000950123-08-001699.txt   33068
Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Subject) CIK: 0001066833 (see all company filings)

EIN.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78237 | Film No.: 08616387
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAHNHOFSTRASSE 45 P O BOX CH 8098 ZURICH V8 -
Business Address BAHNHOFSTRASSE 45 P O BOX CH 8098 ZURICH V8 - 41-1-234-4100
UBS AG (Filed by) CIK: 0001114446 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks